CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
申请人:SANWA KAGAKU KENKYUSHO CO., LTD.
公开号:EP3299357A1
公开(公告)日:2018-03-28
Disclosed herein are a crystal comprising a compound, which has µ-opioid receptor antagonistic action, few side effects, and high safety, and having high purity and excellent physical properties (stability, solubility, etc.), and a method for producing the crystal.
The crystal is a crystal of a salt comprising: a compound represented by a formula (I)
[wherein R2 is a hydrogen atom or a halogen atom, and R1 is a group selected from the group consisting of
]; and an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, and oxalic acid, or a hydrate thereof.
本文公开了一种由化合物组成的晶体,该化合物具有μ-阿片受体拮抗作用,副作用小,安全性高,纯度高,物理性质(稳定性、溶解性等)优良。
该晶体是一种盐的晶体,包括:由式(I)表示的化合物
[其中 R2 是氢原子或卤素原子,R1 是选自以下组别的基团
];以及选自由盐酸、氢溴酸和草酸组成的组中的一种酸或其水合物。